Education
About Us
Working with TipRanks
Follow Us
International Stem Cell (ISCO)
OTHER OTC:ISCO
RESEARCH TOOLSreports
Total Valuation
International Stem Cell has a market cap or net worth of $880.48K. The enterprise value is $3.49M.
Market Cap$880.48K
Enterprise Value$3.49M
Share Statistics
International Stem Cell has 8,004,389 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,004,389
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
International Stem Cell’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is -1.75%.
Return on Equity (ROE)0.05
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-1.75%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee283.91K
Profits Per Employee-6.53K
Employee Count32
Asset Turnover1.76
Inventory Turnover3.28
Valuation Ratios
The current PE Ratio of International Stem Cell is -3.11. International Stem Cell’s PEG ratio is -0.07.
PE Ratio-3.11
PS Ratio0.00
PB Ratio-0.22
Price to Fair Value-0.17
Price to FCF-5.68
Price to Operating Cash Flow67.73
PEG Ratio-0.07
Income Statement
In the last 12 months, International Stem Cell had revenue of 9.09M and earned -209.00K in profits. Earnings per share was -0.03.
Revenue9.09M
Gross Profit5.32M
Operating Income-68.00K
Pretax Income-209.00K
Net Income-209.00K
EBITDA142.00K
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was 13.00K and capital expenditures -168.00K, giving a free cash flow of -155.00K billion.
Operating Cash Flow13.00K
Free Cash Flow-155.00K
Free Cash Flow per Share-0.02
Dividends & Yields
International Stem Cell pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.57
52-Week Price Change20.00%
50-Day Moving Average0.11
200-Day Moving Average0.09
Relative Strength Index (RSI)54.72
Average Volume (3m)1.48K
Important Dates
International Stem Cell upcoming earnings date is Mar 31, 2025, TBA Not Confirmed.
Last Earnings DateMay 16, 2024
Next Earnings DateMar 31, 2025
Ex-Dividend Date―
Financial Position
International Stem Cell as a current ratio of 0.76, with Debt / Equity ratio of -97.71%
Current Ratio0.76
Quick Ratio0.51
Debt to Market Cap5.22
Net Debt to EBITDA18.38
Interest Coverage Ratio-0.47
Taxes
In the past 12 months, International Stem Cell has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
International Stem Cell EV to EBITDA ratio is 22.96, with an EV/FCF ratio of -21.31.
EV to Sales0.36
EV to EBITDA22.96
EV to Free Cash Flow-21.31
EV to Operating Cash Flow250.83
Balance Sheet
International Stem Cell has $1.23M in cash and marketable securities with $3.84M in debt, giving a net cash position of $2.61M billion.
Cash & Marketable Securities$1.23M
Total Debt$3.84M
Net Cash$2.61M
Net Cash Per Share$0.33
Tangible Book Value Per Share-$0.58
Margins
Gross margin is 58.34%, with operating margin of -0.75%, and net profit margin of -2.30%.
Gross Margin58.34%
Operating Margin-0.75%
Pretax Margin-2.30%
Net Profit Margin-2.30%
EBITDA Margin1.56%
EBIT Margin-0.70%
Analyst Forecast
The average price target for International Stem Cell is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast16.64%
EPS Growth Forecast27.03%